Literature DB >> 17049561

Cognitive dimensions in first-episode schizophrenia spectrum disorders.

César González-Blanch1, Benedicto Crespo-Facorro, Mario Alvarez-Jiménez, José Manuel Rodríguez-Sánchez, José María Pelayo-Terán, Rocío Pérez-Iglesias, José Luis Vázquez-Barquero.   

Abstract

BACKGROUND: The severity and pattern of cognitive deficits in epidemiological cohorts of patients with first-episode schizophrenia spectrum disorders still remains unclear. We aimed to characterize the basic cognitive functioning of a representative sample of patients with a first-episode schizophrenia spectrum disorders.
METHOD: One hundred thirty-one patients experiencing first-episode psychosis and 28 healthy volunteers were administered a comprehensive neuropsychological evaluation. To reduce the number of cognitive test measures into meaningful cognitive dimensions, before analyzing differences between patient and healthy volunteer samples, exploratory factor analysis was carried out on data collected in patients group. The method of extraction was Principal Components Analysis with oblique rotation.
RESULTS: An eight-factor model including verbal learning/memory, verbal comprehensive abilities, speed of processing/executive functioning, motor dexterity, motor speed, sustained attention, and impulsivity emerged. A significant below average performance in all cognitive dimensions, except impulsivity, was found. Patient's performance in speed of processing/executive functioning, motor dexterity and sustained attention dimensions exceeded one standard deviation below healthy comparison subjects.
CONCLUSIONS: At early stages of the illness, patients display a marked impairment in several functionally relevant cognitive domains.

Entities:  

Mesh:

Year:  2006        PMID: 17049561     DOI: 10.1016/j.jpsychires.2006.08.009

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  18 in total

1.  Confirmatory factor analysis reveals a latent cognitive structure common to bipolar disorder, schizophrenia, and normal controls.

Authors:  David J Schretlen; Javier Peña; Eleni Aretouli; Izaskun Orue; Nicola G Cascella; Godfrey D Pearlson; Natalia Ojeda
Journal:  Bipolar Disord       Date:  2013-05-09       Impact factor: 6.744

2.  Homocysteine and cognition in first-episode psychosis patients.

Authors:  Rosa Ayesa-Arriola; Rocío Pérez-Iglesias; José Manuel Rodríguez-Sánchez; Ignacio Mata; Elsa Gómez-Ruiz; Maite García-Unzueta; Obdulia Martínez-García; Rafael Tabares-Seisdedos; Jose L Vázquez-Barquero; Benedicto Crespo-Facorro
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-02       Impact factor: 5.270

3.  Prediction of functional outcome in individuals at clinical high risk for psychosis.

Authors:  Ricardo E Carrión; Danielle McLaughlin; Terry E Goldberg; Andrea M Auther; Ruth H Olsen; Doreen M Olvet; Christoph U Correll; Barbara A Cornblatt
Journal:  JAMA Psychiatry       Date:  2013-11       Impact factor: 21.596

4.  Pitch and Duration Mismatch Negativity and Premorbid Intellect in the First Hospitalized Schizophrenia Spectrum.

Authors:  Dean F Salisbury; Nicola R Polizzotto; Paul G Nestor; Sarah M Haigh; Justine Koehler; Robert W McCarley
Journal:  Schizophr Bull       Date:  2017-03-01       Impact factor: 9.306

5.  The impact of psychosis on the course of cognition: a prospective, nested case-control study in individuals at clinical high-risk for psychosis.

Authors:  R E Carrión; D McLaughlin; A M Auther; R Olsen; C U Correll; B A Cornblatt
Journal:  Psychol Med       Date:  2015-07-14       Impact factor: 7.723

6.  Cognitive functioning and negative symptoms in first episode schizophrenia: different patterns of correlates.

Authors:  José Manuel Rodríguez-Sánchez; Benedicto Crespo-Facorro; César González-Blanch; Rocío Pérez-Iglesias; Mario Alvarez-Jiménez; Obdulia Martínez; José Luis Vázquez-Barquero
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

7.  Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone.

Authors:  Rosa Ayesa-Arriola; Jose Manuel Rodríguez-Sánchez; Rocío Pérez-Iglesias; Roberto Roiz-Santiáñez; Obdulia Martínez-García; Jose Sánchez-Moreno; Rafael Tabarés-Seisdedos; Jose L Vázquez-Barquero; Benedicto Crespo-Facorro
Journal:  Psychopharmacology (Berl)       Date:  2013-03-02       Impact factor: 4.530

8.  Apathy, poor verbal memory and male gender predict lower psychosocial functioning one year after the first treatment of psychosis.

Authors:  Ann Faerden; Elizabeth Ann Barrett; Ragnar Nesvåg; Svein Friis; Arnstein Finset; Stephen R Marder; Joseph Ventura; Ole A Andreassen; Ingrid Agartz; Ingrid Melle
Journal:  Psychiatry Res       Date:  2013-03-13       Impact factor: 3.222

Review 9.  The global cognitive impairment in schizophrenia: consistent over decades and around the world.

Authors:  Jonathan Schaefer; Evan Giangrande; Daniel R Weinberger; Dwight Dickinson
Journal:  Schizophr Res       Date:  2013-08-02       Impact factor: 4.939

10.  Diagnosis and neurocognitive profiles in first-episode non-affective psychosis patients.

Authors:  Rosa Ayesa-Arriola; José Manuel Rodríguez-Sánchez; Esther Setién Suero; Lauren E Reeves; Rafael Tabarés-Seisdedos; Benedicto Crespo-Facorro
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-01-14       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.